celastrol has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Hu, C; Hu, G; Liu, M; Ma, K; Wang, S; Xu, N; Zhou, C; Zhu, H | 1 |
| Guo, Y; He, P; Huang, S; Li, J; Li, S; Peng, X; Tang, Y; Wa, Q; Xu, D; Zhang, X; Zuo, J | 1 |
2 other study(ies) available for celastrol and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Celastrol acts as a new histone deacetylase inhibitor to inhibit colorectal cancer cell growth via regulating macrophage polarity.
Topics: Animals; Cell Polarity; Cell Transformation, Neoplastic; Colorectal Neoplasms; Histone Deacetylase Inhibitors; Macrophages; Mice; Pentacyclic Triterpenes; Tumor Microenvironment | 2023 |
Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells.
Topics: Antineoplastic Agents; Argonaute Proteins; Bone Neoplasms; Cadherins; Cell Hypoxia; Cell Proliferation; Cell Transformation, Neoplastic; Epithelial-Mesenchymal Transition; Fibronectins; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Hyaluronan Receptors; Hypoxia-Inducible Factor 1, alpha Subunit; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Neoplasm Invasiveness; Neoplastic Stem Cells; Octamer Transcription Factor-3; Pentacyclic Triterpenes; Prostatic Neoplasms; Spheroids, Cellular; Transcription Factors; Triterpenes; Tumor Cells, Cultured; Vimentin; Zinc Finger E-box-Binding Homeobox 1 | 2015 |